Investors in Ar

Operational early stage investor Pre-seed to Series A. Focus on Climate Tech and Impact. Collaborating with VCs, Syndicates and Accelerators. We actively invest in Pre-Seed to Series A in passionate teams that are looking to scale. Focus on Nordic and Baltic impact and ClimateTech ideas.

Njord Ventures is a seed and early-stage venture capital investor specializing in Swedish entrepreneurial companies. The firm seeks out inspirational entrepreneurs with scalable business models that demonstrate exceptional growth potential driven by technology, macro trends, and disruptions. Njord Ventures prioritizes investing in exceptional individuals who exhibit the determination to achieve extraordinary results.

Carl Westin is an international investment company. They invest in great people with big ideas. Industry agnostic-

Red Pill Invest is a boutique venture capital firm based in Stockholm. We invest in awesome companies and proudly support founders in accelerating growth. Our focus areas are Tech and Health Care. Together with our investor network, we provide more than just capital. We provide smart capital.

The Nordic region is at the forefront of the technology and scientific revolution. Northislet's vision is to help create and build Nordic champions within Life Science, allowing them to grow and reach their potential in the hands of local entrepreneurs, employees, and shareholders. Their goal is to create long-term value for all stakeholders, fostering a prosperous environment for new and existing companies, entrepreneurs, and scientists, making the Nordic region a competitive and attractive place for global talent within Life Science. Northislet aims to become a leading Nordic investment company in Life Science over the next 25 years, with the journey just beginning.

Aligned invests from the pre-seed/seed stage through early growth stages, without focusing on any specific sectors. The firm brings meaningful investment experience, a diverse support network, and a committed partnership to enable founders of all kinds to realize their vision.

We focus on healthcare companies within pharma, biotech, medical technology and health care services and; technology companies within software and hardware. We are primarily interested when the capital and competence we add are required for product or market development. We make investments in companies which are still small and where we can make a difference as owners. We invest in several rounds of financing but limit our initial investment to SEK 10 million. We are looking for a high return which typically is achieved through and exit within 3-5 years. Our investors make a difference for the companies we invest in through the board.

Founded on a passion for the oceans and a commitment to making a difference, Ocean Impact is the Sweden-based investment firm of Fredrik Lind and Robin Ramm-Ericson. Ocean Impact aspires to support entrepreneurs and promising tech companies to fulfill their vision. Fredrik brings 25 years of experience serving technology companies and private equity investors as Senior Partner first at McKinsey & Co. in Singapore, and then at BCG in Stockholm, where he also led ocean policy and sustainability work as areas of expertise. The entrepreneur and unicorn-builder Robin leverages a deep passion for tech and ocean with his experience in actively building tech companies from the first idea to IPO and beyond. As an active owner and partner, Ocean Impact invests in and supports the scaling of tech companies with ocean impact.

Tigrim is a statement, a feeling and a sense of belonging. We believe in people and their visions, helping them grow into sustainable companies. We focus on people and the bright ideas that power our future.

AGV (All Generation Ventures) is the Nordic PropTech platform connecting entrepreneurs, investors, and stakeholders. Its mission is to create the best environment for scaling Nordic PropTech companies. AGV's ecosystem acts as a link between PropTech startups and leading real estate companies, accelerating the digitalization of the Nordic real estate industry.

NXT2B is a fully privately owned venture capital company capable of making fast investment decisions without requiring external capital. The NXT2B team has proven experience in commercializing innovative projects and partners with competent and ambitious entrepreneurs, focusing on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. They are prepared to invest in early-phase projects of high scientific quality and reasonable business potential, as well as in technology and consumer companies with unique ideas. Since its inception in 2011, NXT2B has invested in over 30 companies, offering active support to portfolio management teams to build market-leading companies.

tQuity specializes in early-stage investments, partnering with founders to provide capital, resources, and expertise for developing Minimum Viable Products (MVPs) and implementing business models. Their team, with extensive experience in startups and innovative projects over the past decade, adds smart capital to drive growth and innovation in new ventures.